Buy COF with staged entry at $205-207, $201.50 stop, 40% pre-Q3 trim, and protective puts as binary event insurance
BUY COF at $205-207 with 3-4% target weight (financials sleeve). Entry price $206.00, stop loss at $201.50 (below 200 SMA by ~1 ATR, below August intraday low of $203 with ATR buffer). 40% pre-Q3 trim balances binary event risk against optionality preservation. T1 target $214 (Bollinger Band midline), T2 target $224 (upper BB), T3 target $230+ on Q3 beat and Discover synergy confirmation. Fundamental re-rating target $230-245 over 6-12 months. The 9/14 Underweight has exhausted its empirical alpha ceiling at this price level, the 200 SMA + lower BB convergence is holding, and PEG of 0.19 with ~10% capital return yield creates a structural floor too compelling to ignore. Neither the aggressive analyst's full-throttle conviction nor the conservative analyst's defensive retreat—this is the calibrated verdict the evidence actually supports.
| Position | Action |
|---|---|
| Initiate at $205-207 (200 SMA + lower BB convergence) | Starter position: 50% of target (1.5-2% of portfolio) |
| Close above 50 SMA ($212) on above-average volume | Add-on trigger: deploy remaining allocation |
| Successful test of $202-203 with declining volume | Alternative add-on trigger: deploy remaining allocation |
| Pre-Q3 earnings (late October) | Trim 40% of position to manage binary event risk |
| Daily close below $204 (lower BB breach) on above-average volume | Full exit and reassess for Sell |
| Do NOT reach full target weight ahead of Q3 earnings | Hold 60% position through Q3 print |
Capital One trades at an unjustifiably compressed multiple of 8.6x forward P/E and a PEG of 0.19, having already priced in worst-case credit and macro scenarios that are now being contradicted by a V-shaped operational recovery featuring record FCF, accelerating buybacks, and 32% EPS growth consensus.
| Indicator | Value | Signal |
|---|---|---|
| close_200_sma | 206.24 | neutral |
| close_50_sma | 211.99 | bearish |
| close_10_ema | 210.95 | bearish |
| rsi | 40.42 | neutral |
| macd | −1.48 | bearish |
| macds | +0.09 | bearish |
| macdh | −1.57 | bearish |
| boll | 214.55 | neutral |
| boll_ub | 224.01 | neutral |
| boll_lb | 205.09 | bullish |
| atr | 4.85 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Q2 2026 was the best quarter of the post-merger recovery with $4.73 EPS, revenue stabilized at $15.85B, NII at $12.37B/quarter (24% step-up), and record FCF of $8.1B, while integration charges are declining ($453M → $153M → $415M → $394M), making the credit cycle deterioration narrative incompatible with the data.
↩ rebuts: “Bear's credit cycle deterioration thesis.”
EV: $230-$250 (6-12 month target); 40-50% upside on re-rate to peer multiple; 1:3 to 1:5 near-term tactical risk/reward
COF is a falling knife dressed as a value trap at the peak of a credit cycle—the low multiple reflects legitimate uncertainty about credit deterioration, synergies, and NIM sustainability, not market overreaction.
EV: $185–$195 (6–12 months) · concedes: The bull correctly identifies that COF is not obviously expensive; NIM is currently supported by higher-for-longer rates; Buybacks do provide some mechanical EPS support in the near term; Q2 2026 EPS of $4.73 did represent sequential improvement; The regulatory fight may ultimately be correct long-term
→ vs conservative: Bear-adjusted 8.6x P/E is not deceptive but rather an extreme discount — stressed earnings of ~$17 still put COF at 12x vs peers at 13-15x
→ vs conservative: Waiting for confirmation on credit deterioration means buying at $215+ with less multiple cushion instead of $206 with maximum margin of safety
→ vs conservative: Opportunity cost of sitting in cash while a $12.6B annual buyback machine operates represents 10% annual forced demand
→ vs neutral: MACD/RSI readings in isolation miss the critical context that price is sitting on 200 SMA support and long-term bullish regime (50 SMA above 200 SMA) remains intact
→ vs neutral: Low sentiment score of 4.1/10 is a reason to attack, not avoid — no crowded long to unwind, no euphoria to deflate, just compressed valuation and optionality
→ vs neutral: Q3 binary event is a feature not a bug — pre-earnings drift has compressed entry to 200 SMA, and position sizing already manages the binary risk
Support: 205.09 · 206.24 | Resistance: 210.95 · 211.99 · 214.55 · 224.01
COF trades at a tactical inflection near the 200 SMA (206.24) and lower Bollinger Band (205.09), with the 10 EMA (210.95) and 50 SMA (211.99) acting as overhead resistance. The MACD bearish crossover and expanding histogram (−1.57) indicate bearish momentum conviction, while RSI at 40.42 is neutral—not yet oversold. The long-term bullish regime (50 SMA > 200 SMA) remains intact from the March 174.73 low to the August peak of 227.34. Recommended action is HOLD with entry near 205–207, stop at 202, and targets at 211 and 214.55.
Market Cap
$126.9 billion
P/E (TTM)
11.40
Forward P/E
8.60
PEG Ratio
0.19
Price/Book
1.23
Dividend Yield
1.55%
52-Week High / Low
$259.64 / $174.24
50-Day MA / 200-Day MA
$212.42 / $207.71
Beta
1.016
Revenue (TTM)
$48.1 billion
Net Income (TTM)
$9.82 billion
Profit Margin
21.9%
Operating Margin
33.6%
ROE
9.03%
ROA
1.52%
EPS (TTM)
$18.15
Forward EPS
$24.04
Book Value per Share
$167.86
Q2 2026 Revenue
$15.85 billion
Q2 2026 Net Interest Income
$12.37 billion
Q2 2026 Net Income
$3.02 billion
Q2 2026 Diluted EPS
$4.73
Total Assets (Q2 2026)
$673,835 million
Net Loans (Q2 2026)
$434,466 million
Total Debt (Q2 2026)
$44,677 million
Goodwill (Q2 2026)
$31,866 million
Tangible Book Value (Q2 2026)
$65,850 million
Operating CF (Q2 2026)
$8,444 million
Free Cash Flow (Q2 2026)
$8,077 million
Annualized Capital Return
~$12.6 billion
Share Count Reduction
-4% YoY
Strengths
Concerns
BUY
Macro: 10-year Treasury yield at highest level since 2007 (>4.7%–4.8% zone); oil above $100 keeping term premium elevated and sticky inflation pressures on consumer real income; Fed firmly on hold with Polymarket showing 0% September cut, 4% December cut, 3% October cut; US recession probability at 13% on Polymarket, up 5.5 percentage points week-over-week; UK recession probability at 10%, up 2.5pp; equity markets (Dow, S&P 500, Nasdaq) selling off into September FOMC decision day.